Skip to main content
Clinical Trials/NCT01368835
NCT01368835CompletedNot Applicable

Evaluation of the Ulthera™ System For Obtaining Lift and Tightening of the Cheek Tissue and Improvement in Jawline Definition and Submental Skin Laxity

Ulthera, Inc0 sites103 target enrollmentStarted: July 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
103
Primary Endpoint
Change in Overall Lifting and Tightening of Treated Tissue on the Lower Face and Submental Regions.

Study Overview

Brief Summary

The clinical trial evaluates the clinical outcomes associated with the non-invasive treatment to obtain lift and tightening of the cheek tissue and improve jawline definition and submental skin laxity utilizing the Ulthera™ System which delivers ultrasound energy in a focused manner below the surface of the skin

Detailed Description

The primary objective of this study is to demonstrate the effectiveness of the Ulthera™ System for the non-invasive dermatological treatment to obtain lift and tighten the cheek tissue.

The secondary objective of this study is to demonstrate the effectiveness of the Ulthera™ System for the non-invasive dermatological treatment for improvement in jawline definition and submental skin laxity at 3 and 6 months compared to baseline based on the consensus of the three masked reviewers.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
35 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Male or female, aged 35 to 60 years
  • •Subject in good health
  • •Desire lift and tightening of cheek tissue, improvement of jawline definition or submental skin laxity

Exclusion Criteria

  • •Pregnant or lactating
  • •Has an active systemic or local skin disease that may alter wound healing
  • •Severe solar elastosis
  • •Excessive subcutaneous fat on the cheeks
  • •Excessive skin laxity on the lower face and neck
  • •Has significant scarring in areas to be treated
  • •Has significant open facial wounds or lesions
  • •Has severe or cystic acne on the face

Arms & Interventions

Ulthera treatment

Experimental

Intervention: Ulthera treatment (Device)

Outcomes

Primary Outcomes

Change in Overall Lifting and Tightening of Treated Tissue on the Lower Face and Submental Regions.

Time Frame: 90D

The percentage of participants assessed to have improvement in skin laxity, i.e., lifted and tightened skin in the areas treated with the Ulthera System, as determined by three masked assessors comparing pre-treatment and 90-days post-treatment photos from 70 subjects who returned for their 90-day follow-up visit.

Secondary Outcomes

  • Change in Submental and Neck Skin Laxity by Quantitative Analysis(90D)
  • Patient Satisfaction Questionnaire(90D)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials